Literature DB >> 9770079

The role of herpes simplex virus glycoproteins in the virus replication cycle.

J Rajcáni1, A Vojvodová.   

Abstract

At least nine of the eleven herpes simplex virus (HSV) glycoproteins so far known have been widely characterised as regards their role in the virus replication cycle. During early virus-to-cell adsorption ("adsorption"), glycoprotein C (gC) interacts with the glycosoaminoglycan (GAG) heparan sulphate (HS), located on the cell membrane surface. This interaction is labile until other glycoproteins such as B and D (gB and gD) begin to participate in the entry process. gB also harbours a site for interaction with GAGs, while gD provides a stabile attachment to cellular receptors ("receptors") such as the herpesvirus entry mediator (HVEM). Late adsorption is associated with a conformation change of gD occurring after the receptor binding, a step followed by interaction of gD with the gH/gL heterodimer (complex). Fusion domains of the gH/gL complex and gB enable the pH-independent virus-into-cell penetration ("penetration"). The gE/gI complex and gM interact with the receptors at cell junctions in order to facilitate cell-to-cell spread of the virus along the basolateral surface of polarised cells and/or a similar intercellular spread in nonpolarised cells by avoiding virion release, gK, the only so far known HSV-coded glycoprotein which is not incorporated into virions, plays an essential role in the virus capsid envelopment at the nuclear membrane and in the virion transport to the cell surface. Unusually large polykaryocytes arise due to mutations in syn (syncytium) loci of the viral genome, which were mapped to UL53 (syn1) and UL27 (syn3) genes coding for gK and gB, respectively, while the genes UL20 and UL24 (both syn5) code for nonglycosylated cell membrane-associated proteins ("membrane proteins"). The products of nonmutated syn genes either downregulate the fusion of plasma membranes of infected cells ("membrane fusion") or protect them from undesirable fusion events.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770079

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  23 in total

1.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Description of a nonlethal herpes simplex virus type 1 glycoprotein D deletion mutant affecting a site frequently used for PCR.

Authors:  P V Coyle; S Jain; D Wyatt; C McCaughey; H J O'Neill
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 3.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

4.  An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI.

Authors:  S M Rizvi; M Raghavan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 5.  Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion.

Authors:  J Rajcáni; M Kúdelová
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

6.  Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain.

Authors:  Russell J Diefenbach; Monica Miranda-Saksena; Eve Diefenbach; David J Holland; Ross A Boadle; Patricia J Armati; Anthony L Cunningham
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Herpes simplex virus 1 envelopment follows two diverse pathways.

Authors:  Helene Leuzinger; Urs Ziegler; Elisabeth M Schraner; Cornel Fraefel; Daniel L Glauser; Irma Heid; Mathias Ackermann; Martin Mueller; Peter Wild
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 8.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

9.  Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Authors:  R Leskowitz; M H Fogg; X Y Zhou; A Kaur; E L V Silveira; F Villinger; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.